Player FM - Internet Radio Done Right
Checked 16d ago
Ditambah nine tahun yang lalu
Kandungan disediakan oleh The Immune-Mediated Inflammatory Disease Forum. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The Immune-Mediated Inflammatory Disease Forum atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !
Pergi ke luar talian dengan aplikasi Player FM !
Discussing RA: Insights into sustained DMARD-free remission and barriers to CAR T-cell therapy
Manage episode 462815757 series 1044916
Kandungan disediakan oleh The Immune-Mediated Inflammatory Disease Forum. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The Immune-Mediated Inflammatory Disease Forum atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, Professor McInnes discusses two papers: subgroups of patients with early RA with or without bDMARD who reached sustained DMARD-free remission and barriers to the widespread adoption of CAR T-cell therapy in rheumatic diseases.
…
continue reading
339 episod
Manage episode 462815757 series 1044916
Kandungan disediakan oleh The Immune-Mediated Inflammatory Disease Forum. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The Immune-Mediated Inflammatory Disease Forum atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, Professor McInnes discusses two papers: subgroups of patients with early RA with or without bDMARD who reached sustained DMARD-free remission and barriers to the widespread adoption of CAR T-cell therapy in rheumatic diseases.
…
continue reading
339 episod
Semua episod
×
1 Author Interview: Professor Denis McGonagle, 2025 36:01
36:01
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai36:01
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Denis McGonagle, Professor of investigative rheumatology at the NIHR funded Academic Unit for the Musculoskeletal Diseases and Leeds Teaching Hospitals NHS Trust in the UK, as they discuss his recent review ‘Subclinical psoriatic arthritis and disease interception—where are we in 2024?’…

1 Discussing RA: Insights into sustained DMARD-free remission and barriers to CAR T-cell therapy 11:18
11:18
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai11:18
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, Professor McInnes discusses two papers: subgroups of patients with early RA with or without bDMARD who reached sustained DMARD-free remission and barriers to the widespread adoption of CAR T-cell therapy in rheumatic diseases.…

1 Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib 18:42
18:42
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai18:42
Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenfon Baraliakos to discuss a recent study on the efficacy and safety of upadacitinib in patient with ankylosing spondylitis.…

1 Discussing RA: Insights into Filgotinib and Tofacitinib in RA 24:13
24:13
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai24:13
Join Professor Iain McInnes and Professor Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.…
ACR 2024 Review Podcast by The Immune-Mediated Inflammatory Disease Forum

1 PsA Podcast: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses 30:53
30:53
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai30:53
Join Professors Peter Nash and Philip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered a post hoc analysis examining the rapid and sustained efficacy of bimekizumab in PsA patients across different subgroups, focusing on improvements in pain, fatigue, and physical function over 16 weeks. The conversation also covered a long-term analysis of guselkumab assessing the durability of clinical improvements in joint and skin symptoms in PsA patients over a 2-year period.…

1 Discussing RA: Insights into Filgotinib and Tofacitinib in RA 19:16
19:16
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai19:16
Join Professor Iain McInnes and Professor Johannes Bijlsma for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.…

1 Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases 26:39
26:39
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai26:39
Webinar Highlights Podcast: Join Professor Iain McInnes and Professor Georg Schett as they discuss the recent webinar hosted on the IMID Forum: “CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases”. Listen to them discuss key highlights from the webinar including the development of CAR T-cell therapy, the application of CAR T to autoimmune diseases, and the potential risks and reservations associated with this therapeutic approach.…
ACR 2024 Highlights: Day 3 by The Immune-Mediated Inflammatory Disease Forum
ACR 2024 Highlights: Day 2 by The Immune-Mediated Inflammatory Disease Forum
ACR 2024 Highlights: Day 1 by The Immune-Mediated Inflammatory Disease Forum
ACR 2024: Preview Podcast by The Immune-Mediated Inflammatory Disease Forum

1 AxSpA Podcast: Efficacy and Safety of IV secukinumab 23:30
23:30
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai23:30
Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, and Atul Deodhar to discuss a recent study on the efficacy and safety of IV secukinumab in patient with active axSpA.

1 Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy 22:03
22:03
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai22:03
Join Professor Iain McInnes and Professor Leonard Calabrese for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which investigate the efficacy and safety of JAK inhibitors and TNF inhibitors for rheumatoid arthritis, while also uncovering the best treatment strategies for difficult-to-treat RA.…

1 Author Interview: Derin Karacabeyli, 2024 33:27
33:27
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai33:27
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Derin Karacabeyli of Arthritis Research Canada, a rheumatologist and resident in the University of British Columbia Clinician Investigator Program, as they discuss his recent paper ‘Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study’, published in PLoS One on 08th August 2024.…
Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.